Literature DB >> 18177973

Effect of corosolic acid on gluconeogenesis in rat liver.

Kotaro Yamada1, Masaya Hosokawa, Shimpei Fujimoto, Hideya Fujiwara, Yoshihito Fujita, Norio Harada, Chizumi Yamada, Mitsuo Fukushima, Naoya Ueda, Tetsuo Kaneko, Futoshi Matsuyama, Yuichiro Yamada, Yutaka Seino, Nobuya Inagaki.   

Abstract

Corosolic acid (CRA), an active component of Banaba leaves (Lagerstroemia speciosa L.), decreases blood glucose in diabetic animals and humans. In this study, we investigated the mechanism of action of CRA on gluconeogenesis in rat liver. CRA (20-100 microM) dose-dependently decreased gluconeogenesis in perfused liver and in isolated hepatocytes. Fructose-2,6-bisphosphate (F-2,6-BP), a gluconeogenic intermediate, plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. CRA increased the production of F-2,6-BP along with a decrease in intracellular levels of cAMP both in the presence and in the absence of forskolin in isolated hepatocytes. While a cAMP-dependent protein kinase (PKA) inhibitor inhibited hepatic gluconeogenesis, the drug did not intensify the inhibitory effect of CRA on hepatic gluconeogenesis in isolated hepatocytes. These results indicate that CRA inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes. Furthermore, CRA increased glucokinase activity in isolated hepatocytes without affecting glucose-6-phosphatase activity, suggesting the promotion of glycolysis. These effects on hepatic glucose metabolism may underlie the various anti-diabetic actions of CRA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18177973     DOI: 10.1016/j.diabres.2007.11.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Lipopolysaccharide inhibits hepatic gluconeogenesis in rats: The role of immune cells.

Authors:  Hiroshi Tanaka; Yoshikazu Nishikawa; Toru Fukushima; Ataru Taniguchi; Yoshihito Fujita; Kinsuke Tsuda; Nobuya Inagaki; Masaya Hosokawa
Journal:  J Diabetes Investig       Date:  2017-08-14       Impact factor: 4.232

2.  Corosolic acid isolated from Eriobotrya japonica leaves reduces glucose level in human hepatocellular carcinoma cells, zebrafish and rats.

Authors:  Shuwen Xu; Gang Wang; Wei Peng; Yandi Xu; Yu Zhang; Ying Ge; Yue Jing; Zhunan Gong
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

3.  Management of Diabetes and Its Complications with Banaba (Lagerstroemia speciosa L.) and Corosolic Acid.

Authors:  Toshihiro Miura; Satoshi Takagi; Torao Ishida
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

4.  A blend of phellodendron and crape myrtle improves glucose tolerance in exercise-trained men.

Authors:  Robert E Canale; Tyler M Farney; Cameron G McCarthy; Richard J Bloomer
Journal:  Nutr Metab Insights       Date:  2011-09-13

5.  Corosolic acid inhibits the proliferation of glomerular mesangial cells and protects against diabetic renal damage.

Authors:  Xiao-Qiang Li; Wen Tian; Xiao-Xiao Liu; Kai Zhang; Jun-Cheng Huo; Wen-Juan Liu; Ping Li; Xiong Xiao; Ming-Gao Zhao; Wei Cao
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.